Warren Buffett is one of the most successful investors of all time. Few, if any, will ever have the means to replicate the nearly $300 billion investment portfolio of Berkshire Hathaway (NYSE:BRK.B). The average investor, however, can be successful in their own right by following the advice and actions of Buffett. Looking across the list
Month: January 2022
It’s true. I don’t understand GameStop (NYSE:GME) stock or its followers. I say that because I recently received an angry inbox message claiming I didn’t do my homework in regard to GameStop. Source: Shutterstock Well, I did. I mean, I looked at the company from a fundamental perspective. What I saw didn’t look appealing. There
In this article CROX DASH BIIB A person skateboards past Biogen Inc. headquarters in Cambridge, Massachusetts, on Monday, June 7, 2021. Adam Glanzman | Bloomberg | Getty Images Check out the companies making headlines in midday trading Wednesday. Biogen — Shares of Biogen fell more than 9% after Medicare said it would only cover the
Federal Reserve Board (FRB) Chair Jerome Powell indicated, during his confirmation hearing with the U.S. Senate Banking Committee, that high inflation poses a “severe threat” to the U.S. economic recovery. To combat inflation, he said that the Fed is prepared to raise interest rates, particularly since he believes that the economy no longer needs emergency
As recently shown, investing in Allakos (NASDAQ:ALLK) proves the inherent danger within the biopharmaceutical sector. After reaching a 52-week high of more than $157, ALLK stock plunged late in December and now sits just above $8 per share. Source: luchschenF / Shutterstock.com Biopharma companies often live and die by the initial success of a single
After decades in hibernation, inflation woke up in 2021 in a terrible rage. The consumer price index increased 7% in 2021, the fastest pace in 39 years. The inflation story is bound to be a big one in 2022 as well, as the Federal Reserve tightens monetary policy, stock markets SPX, +0.15% DJIA, -0.05% tremble
Nvidia (NASDAQ:NVDA) emerged as one of the biggest stock market winners last year. NVDA stock generated over 120% returns for its investors in the past 12-months. Though its share price has gotten slightly ahead of itself, the chipmakers glowing reports justify its lofty valuation. Moreover, there’s still plenty of upside remaining with Nvidia, with it
February is a few weeks away. That’s a fairly short window in which to decide to sell for some investors. For traders, obviously that’s a much less important consideration. In either case, both types of investor have reason to believe specific equities have a reasonable chance of declining before then. It’s led to speculation on
A used car dealership is seen in Annapolis, Maryland on May 27, 2021, as many car dealerships across the country are running low on new vehicles as a computer chip shortage has caused production at many vehicle manufactures to nearly stop. Jim Watson | AFP | Getty Images A key measure of consumer prices is
Some of the most sought-after stocks are those that come with a hefty price tag. That’s because many of us equate value with price. The higher the price, the more valuable and, therefore, the more desirable a company becomes. But let’s face it, the average investor may not be able to afford a single share
With Covid-19 concerns fading and travel stocks attracting attention in today’s market, it is only natural that investors will be looking to capitalize on this opportunity. The United States just removed its travel restrictions for international travelers and other countries are following in its footsteps. The White House has announced that Dr. Anthony Fauci, the
“‘What a moron. Jesus Christ.’” — Dr. Anthony Fauci, after questioning from Sen. Roger Marshall On Tuesday, Dr. Anthony Fauci delivered testimony from critical Republican senators who accused the government’s top infectious disease expert of trying to “take down” some scientists who disagreed with him. But it was something that Fauci didn’t mean for the
Shane Evans, interim CEO of fintech platform MX. Courtesy: MX Fintech start-up MX has named Shane Evans its interim CEO as the company prepares for an initial public offering or possible sale, CNBC has learned. Evans, who joined the Utah-based start-up in 2019 as chief revenue officer, is replacing founder Ryan Caldwell, who will become
We highlight top performing ETF areas of the first quarter. zacks.com zacks.com/ultimate
Recently a number of reports emerged, including a Jan. 5 article in Barron’s magazine, that Charlie Munger has “doubled down” into shares of Alibaba Group Holding (NYSE:BABA). In the past, I have written why BABA stock looks cheap. But I wanted to write about why he might see Alibaba as a worthwhile investment to buy
The omicron Covid-19 variant has taken its toll on cruise stocks. The three cruise ship giants in Royal Caribbean (NYSE:RCL), Carnival (NYSE:CCL), and Norwegian Cruise Line (NYSE:NCLH) have all seen their shares tumble in recent days. Adding to their woes, the Centers for Disease Control came out with a warning to “avoid cruise travel, regardless
In this article LVS ACI JNPR RIVN ILMN Offices of Illumina, in San Diego, California. Mike Blake | Reuters Check out the companies making headlines in midday trading. Illumina – Illumina shares surged 12.7% a day after the biotechnology company issued a 2022 revenue outlook that topped consensus expectations. The company also highlighted strong demand for
With hundreds of millions of users around the world, Twitter (TWTR) is one of the world’s most popular social media sites. In fact, it’s one of the 20 most-used social-media platforms in the world. Users post tweets and interact with each other using 280 characters or less. The site has become a place for people to debate
Right after Thanksgiving, when omicron and the Fed scared the markets, it appeared likely that AMC Entertainment (NYSE:AMC) was ready to capitulate. In my view, changes in market sentiment was going to be what finally took AMC stock, one of the meme stock legends, down to a price more in line with its fundamentals. Source: rblfmr/Shutterstock.com
With COVID-19 infections reaching peak levels, Walgreens Boots Alliance Inc. should get a boost from demand for vaccine administration and at-home testing, Mizuho analysts say. Walgreens WBA, +0.83% reported fiscal first-quarter results that beat expectations last week, and raised its full-year outlook. The pharmacy retailer also announced that has created a new healthcare reporting segment
- « Previous Page
- 1
- …
- 13
- 14
- 15
- 16
- 17
- …
- 22
- Next Page »